Cart
sales@molnova.com
BT18
CAS No. 924811-53-0
BT18( —— )
Catalog No. M24975 CAS No. 924811-53-0
BT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 107 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 250 | In Stock |
|
| 50MG | 370 | In Stock |
|
| 100MG | 547 | In Stock |
|
| 200MG | 792 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBT18
-
NoteResearch use only, not for human use.
-
Brief DescriptionBT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF).
-
DescriptionBT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF). BT18 has an effect on RET receptor tyrosine kinase RetA and GDNF family receptor GFRα1 function.
-
In VitroBT18 (50 μM; 1-90 minutes) activates AKT and ERK1/2 in time-dependently in MG87RET cell lines.BT18 (1-50 μM; 90 minutes) activates AKT in a dose-dependent manner in MG87RET cell lines.BT18 (5-50 μM; 15 mimutes) appears to phosphorylate RET in concentration of 50 μM both in GFP-transfected and in GFRD1-transfected cells. Western Blot Analysis Cell Line:MG87RET cell lines Concentration:50 μM Incubation Time:1, 5, 15, 45, 90 minutes Result:Activated AKT and ERK1/2 in time-dependently.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number924811-53-0
-
Formula Weight637.64
-
Molecular FormulaC30H31F4N3O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 98 mg/mL (153.69 mM; Need ultrasonic)
-
SMILESCOc(ccc(S(N(CC1)Cc(cc2OC)c1cc2OC)(=O)=O)c1)c1N(CC1)CCN1C(c(cc1)c(C(F)(F)F)cc1F)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
TCMDC-135051
TCMDC-135051 is a potent and selective PfCLK3 protein kinase inhibitor demonstrating significant antiparasiticidal activity (EC50=320 nM) while exhibiting minimal off-target toxicity.
-
Fudosteine
Fudosteine is a novel mucoactive agent and a MUC5AC mucin hypersecretion inhibitor.
-
Carbaglu
Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death.
